Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Intellipharmaceutics International Inc.

TRADE

NASDAQ: IPCIHealthcare / Drug Delivery / Canada
2.51-0.22-8.06%Vol 47 8641Y Perf -72.28%
Sep 18th, 2018 15:59
BID2.51 ASK2.73
Open2.75 Previous Close2.73
Pre-Market- After-Trading-
 - -%  - -%
Target Price
27.50 
Analyst Rating
Moderate Buy 1.67
Potencial %
995.62 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
     38.22
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)11 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
2.06 
Earnings Date
9th Oct 2018

Today's Price Range

2.332.75

 

52wk Range

2.3012.50

Summary:

Neutral

Technical Indicators: Sell
Moving Averages: Buy
Performance
1 Month
875.00%
3 Months
480.85%
6 Months
313.64%
1 Year
-72.28%
3 Years
26.98%
5 Years
34.48%

Quotes

Name / TickerPriceChg.Chg.%
IPCI2.51-0.2200-8.06
AAPL218.240.36000.17
GOOG1 161.225.17000.45
MSFT113.211.07000.95
XOM83.630.22000.26
WFC54.500.19000.35
JNJ140.540.58000.41
FB160.30-0.2800-0.17
GE12.66-0.0400-0.31
JPM114.300.46000.40
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.50
Current Ratio 0.60
Long Term Debt to Total Capital -
Total Debt to Equity 3.34
Interest Coverage -25.50
Leverage Ratio -5.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin82.40
EBIT Margin-335.10
EBITDA Margin-315.60
Pre-tax Profit Margin-318.10
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 62.79
PS Ratios 4.67
Price to Cash Flow -
Price to Free Cash Flow -1.70
Cash Flow Per Share -3.18
Price to Tangible Book-12.62
Book Value per Share-0.24
Enterprise Value (in ths.)14 510
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)445 241.00
ROE last 12 Months 11 680.60
Return on Assets (5Y Avg) -107.91
ROA last 12 Months -149.78
Return on Capital (5Y Avg) -
ROC last 12 Months -189.03
Return on invested Capital Q -189.03
Return on invested Capital Y-387.94
Assets Turnover0.30
Receivables Turnover1.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)1 989
Revenue per Share 0.63
Revenue Growth 3 Years -9.00
Revenue Growth 5 Years 107.70
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.70-0.700.00
Q01 2018-0.50-0.90-80.00
Q04 2017-0.70-0.80-14.29
Q03 2017-0.40-0.80-100.00
Q02 2017-0.50-0.60-20.00
Q01 2017-0.08-0.0712.50
Q04 2016-0.06-0.14-133.33
Q03 2016-0.07-0.070.00
Earnings Per EndEstimateRevision %Trend
5/2018 QR-0.07-40.00Negative
8/2018 QR-0.0420.00Positive
11/2018 FY-0.100.00-
11/2019 FY-0.03-160.00Negative
Next Report Date9th Oct 2018
Estimated EPS Next Report-0.40
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume47 864
Shares Outstanding (in ths.)4 350
Trades Count166
Dollar Volume104 796
Avg. Volume28 586
Avg. Weekly Volume49 135
Avg. Monthly Volume40 829
Avg. Quarterly Volume19 180

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

42%58%

Bearish Bullish

50%50%

Bearish Bullish

63%37%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.67
Moderate Buy
1.67
Moderate Buy
1.67

There are no comments yet.

News

x